Samsung Biologics IPO to raise $2b, move seen as new growth engine for parent

Samsung Biologics IPO to raise $2b, move seen as new growth engine for parent

Jungah Lee

04 October, 2016

Citigroup IncCredit Suisse Group AGJPMorgan Chase & CoKorea Investment & Securities CoNH Investment & Securities Co.Samsung Biologics Co

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.